FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a pharmaceutical composition containing Ac-Arg-cyclo(Cys-D-Ala-His-D-Phe-Arg-Trp-Cys)-NH2 pamoate, which is a melanocortin receptor ligand subtype 4 (MC4-R) and in which after subcutaneous or intramuscular administration into an individual, the peptide forms a depot with physiologically value pH, which dissolves slowly and is released into body fluid and blood flow. The present invention also contains polyethylene glycol (PEG) at an average molecular weight from approximately 200 to approximately 400.
EFFECT: present invention possesses high effectiveness associated with a smooth release profile.
24 cl, 12 dwg, 6 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HYDANTOIN MODIFIED MELANOCORTIN RECEPTOR LIGANDS | 2008 |
|
RU2450017C2 |
| MELANOCORTIN RECEPTOR LIGANDS | 2006 |
|
RU2380372C2 |
| MELANOCORTIN RECEPTOR LIGANDS | 2006 |
|
RU2439079C2 |
| PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
| PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
| PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2690377C2 |
| METHOD FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCORTIN 4 RECEPTOR PATH | 2016 |
|
RU2785889C1 |
| 1-(4-AMINO-5-BROMO-6-(1H-PYRAZOL-1-YL)PYRIMIDIN-2-YL)-1H-PYRAZOL-4-OL AND ITS APPLICATIONS FOR CANCER TREATMENT | 2018 |
|
RU2791531C2 |
| LIGANDS OF MELANOCORTIN RECEPTORS | 2006 |
|
RU2401841C2 |
| ANTIGEN-BINDING PROTEINS AGAINST TIGIT AND THEIR APPLICATION METHODS | 2018 |
|
RU2776714C2 |
